Pacific Biosciences of California
PACB
2.72
+0.02
+0.74%
Pacific Biosciences of California
US · PACB
#3373 by market cap
2.72
+0.02
+0.74%
Live - 5344 symbols - heartbeat 468s ago
· 2026-10-08 09:10
Pre-market
2.65
-2.57%
After-hours
2.70
-0.74%
Overnight
2.72
0.00%
- Market cap
- 845.46M
- P/E (TTM)i
- -6.48
- P/Bi
- -25.42
- EPSi
- -1.82
- Div yieldi
- 0.00%
- 52W posi
- 70%
Reader sentiment
Are you bullish or bearish on PACB?
Anonymous reader poll. Unscientific, not investment advice.
About Pacific Biosciences of California
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
- Founded
- 2000
- CEO
- Mr. Mark Van Oene
- Employees
- 485
- Headquarters
- Menlo Park, California, United States of America
- Fiscal year end
- 12-31
- Website
- pacb.com
Company profile
- Exchange
- US
- Symbol
- PACB
- Market-cap rank
- #3373
- Market cap
- 845.46M
- Float cap
- 826.91M
- Shares out
- 310.83M
- Float shares
- 304.01M
Sectors & themes
Quote time 2026-10-08 09:10:31 · For reference only, not investment advice and not tailored to your situation.